Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TwiLyte: Bitopertin in sub-optimally controlled schizophrenia
NCT01235520Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of bitopertin in schizophrenia, sponsored by Roche. Started Jan 2011; status: completed.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01235520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235520.